alexa
Reach Us +441467840001
Perspectives on Carbon Nanotube-Based Scaffolds in Nerve Tissue Engineering | OMICS International | Abstract
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Perspectives on Carbon Nanotube-Based Scaffolds in Nerve Tissue Engineering

Shang-Tian Yang* and Ru Zang

Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA

Corresponding Author:
Dr. Shang-Tian Yang
Professor, Department of Chemical and Biomolecular Engineering
The Ohio State University, 140 West 19th Avenue
Columbus, Ohio 43210, USA
Tel: (614) 292-6611
Fax: (614) 292-3769
E-mail: [email protected]

Received date: December 14, 2011; Accepted date: December 20, 2011; Published date: December 22, 2011

Citation: Yang S, Zang R (2012) Perspectives on Carbon Nanotube-Based Scaffolds in Nerve Tissue Engineering. J Tissue Sci Eng 3:e108. doi:10.4172/2157-7552.1000e108

Copyright: © 2012 Yang S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

To improve the health and quality of life of patients suffering from neural degeneration diseases or brain and spinal cord injuries, much research has been dedicated to the repairing and regeneration of neural tissues. Although allogenic grafts have no supply limitation, they often cause undesirable immune responses. Thus, autologous grafts are usually used to treat neural defects. However, the short life of nerves and a mismatch of nerve cable dimension between the donor graft and the receptor nerve limit its clinical applications. Nerve tissue engineering has emerged as a highly promising alternative strategy to neural therapy, aimed at rebuilding the lesioned circuits of the central and peripheral nervous systems, while minimizing body’s immune responses with engineered nerves.

Share This Page
Top